Biopharma | May 13, 2026
Agilent and Veeda collaborate to strengthen regulatory-ready biopharma analytics
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
The private funding rose 38% amid growing international collaborations and CDMO demand
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Replicate will receive research funding and could potentially receive up to approximately US$550 million
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Executes the first project for developing and manufacturing a novel anticancer mAb
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Subscribe To Our Newsletter & Stay Updated
